Ascomycins: promising agents for the treatment of inflammatory skin diseases

By Paul C.   Graeber M.   Stuetz A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Fc-fusion Proteins in Therapy: An Updated View

By  

Current Medicinal Chemistry, Vol. 24, Iss. 12, 2017-06 ,pp. : 1228-1237

Bentham Science Publishers

Access to resources Recommend Favorite

Viral Anti-Inflammatory Proteins: The Potential for Immunotherapeutic Applications in Cancer

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 2, 2008-06 ,pp. : 130-149

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Inhibitors of Nuclear Factor of Activated T Cells: Potential Therapeutic Drugs for the Treatment of Immunological and Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 1, 2008-03 ,pp. : 35-40

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 482-501

Bentham Science Publishers

Access to resources Recommend Favorite